We are an international team of scientists dedicated to exploring some of the most exciting and challenging questions of life.Our topics range from stem cell research and the investigation of mechanisms that control the formation of blood vessels to research on inflammation processes.

Welcome to the
Max Planck Institute for Molecular Biomedicine

We are an international team of scientists dedicated to exploring some of the most exciting and challenging questions of life.
Our topics range from stem cell research and the investigation of mechanisms that control the formation of blood vessels to research on inflammation processes.

News

Research on the corona virus: contributions from the Max Planck Society

On this topic page the Max Planck Society collects contributions from various research fields at Max Planck Institutes, all of which are related to the corona pandemic.

New brochure "High-Performance Computing and Data Science in the MPG"

August 11, 2021
Contribution by Jan Huertas, Hans Schöler and Vlad Cojocaru of the MPI for Molecular Biomedicine

First synthetic tissue model developed in which blood vessels can grow

July 27, 2021
Researchers investigate which material properties support vessel formation

Career

How to join us

On these pages, you will find information on how to join the Max Planck Institute for Molecular Biomedicine, be it as an intern, scientist or as a trainee.

Career and family

As the first German research organisation, the Max Planck Society was granted the logo of the non-profit organisation berufundfamilie (“career and family”), honouring the family-oriented personnel policy.

More detailed information on equal opportinuties at the Max Planck Institute for Molecular Biomedicine are found under this menu option.

Equality

Talent, creativity and passion - those are the qualities the Max Planck Society relies on. The Society supports employees irrespective of their gender, nationality, religion, disabilities, age, cultural background or sexual identity. After all, the basis for the cutting-edge research
Go to Editor View